The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Are The Forecasted Market Size Figures For The Blood Transfusion Diagnostics Market In 2026 And 2030?
The blood transfusion diagnostics market has experienced robust growth in recent years. It is projected to expand from $4.96 billion in 2025 to $5.35 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 7.9%. Historically, this market’s expansion can be linked to factors such as the limited availability of advanced blood diagnostics instruments, a prevalent reliance on manual blood grouping methods, an increase in hospital blood transfusion procedures, the rising incidence of transfusion-transmissible infections, and a scarcity of standardized reagents and kits.
Significant expansion is anticipated for the blood transfusion diagnostics market in the coming years. Projections indicate its value will reach $6.86 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4%. This growth throughout the forecast period stems from several factors, including the creation of high-throughput automated blood screening systems, a growing need for nucleic acid amplification and rapid testing, increased funding for blood banks and diagnostic laboratories, the integration of digital and AI-powered diagnostic solutions, and the broadening of plasma fractionation and research endeavors. Key trends shaping this period encompass an escalating demand for swift and precise blood typing, the wider acceptance of automated blood processing systems, an enlargement of disease screening functionalities, the expansion of plasma fractionation and diagnostic laboratories, and a heightened emphasis on standardization and quality control.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2494&type=smp
Which Core Factors Are Supporting The Expansion Of The Blood Transfusion Diagnostics Market?
The blood transfusion diagnostics market is projected to expand due to the increasing volume of surgical procedures, which are medical interventions addressing injuries, diseases, or disorders. The rising global number of surgeries necessitates more safe and compatible blood transfusions to replenish blood lost. Blood transfusion diagnostics are vital for screening and matching donor blood, thereby preventing infections and complications and ensuring patient safety. For example, data from June 2024 by the American Society of Plastic Surgeons, a US-based non-profit, indicates that minimally invasive procedures grew by 7% in 2023, surpassing the growth of surgical procedures by 2%. Hand surgeries, including carpal tunnel, arthritis, and trigger finger, reached 207,887 procedures, marking a 2% increase from 2022. Consequently, the expanding number of surgical procedures is a key impetus for the blood transfusion diagnostics market. The increasing occurrence of blood-related diseases is anticipated to boost the expansion of the blood transfusion diagnostics market. These diseases include various conditions impacting blood composition, function, or production, such as anemias, leukemia, and clotting disorders. Blood transfusion diagnostics are crucial for the early identification and secure handling of these conditions, ensuring appropriate blood products and lowering the risk of patient complications. For example, in January 2023, the American Cancer Society Inc., a US-based professional organization, reported approximately 59,610 new cases of leukemia (all types) and 23,710 deaths from leukemia (all types). Additionally, about 20,380 new cases of acute myeloid leukemia (AML) were noted. Hence, the rising prevalence of blood-related diseases is a significant factor propelling the growth of the blood transfusion diagnostics market.
How Is The Blood Transfusion Diagnostics Market Structured Across Different Market Segments?
The blood transfusion diagnostics market covered in this report is segmented –
1) By Type: Instruments And Kits, Reagents, Other Types
2) By Technology: Western Blot, ELISA, Nucleic Acid Amplification, Fluorescence Assay, Rapid Test
3) By Application: Blood Grouping, Disease Screening
4) By End User: Hospitals, Diagnostic Laboratories, Blood Banks, Plasma Fractionation Companies
Subsegments:
1) By Instruments And Kits: Blood Typing Instruments, Cross-Matching Kits, Blood Screening Instruments, Automated Blood Processing Systems
2) By Reagents: Antisera, Control Solutions, Blood Grouping Reagents, Enzymes And Other Reagents
3) By Other Types: Software Solutions, Consumables, Training And Support Services
What Trends Are Influencing The Blood Transfusion Diagnostics Market Outlook?
Leading companies in the blood transfusion diagnostics market are developing advanced technologies, including innovations in transfusion technology, to improve the accuracy of blood typing, enhance patient safety, reduce the risk of transfusion-transmitted infections, and optimize the overall transfusion process. These innovations involve advancements and improvements in the methodologies, devices, and procedures employed in blood transfusion. For example, in June 2024, Innobiochips Co. Ltd., a France-based biotechnology company, launched Omnys, a significant innovation for transfusion, grouping, and blood testing. This state-of-the-art diagnostic platform is designed to provide rapid and accurate blood typing, compatibility testing, and pathogen detection. The innovative technology utilizes advanced biomarker identification and automation to streamline the transfusion process, ensuring that blood products are safely matched to patients.
Who Are The Companies Shaping The Blood Transfusion Diagnostics Market Landscape?
Major companies operating in the blood transfusion diagnostics market are Fresenius Kabi AG, Becton Dickinson and Company, Baxter International Inc., Medline Industries LP, Grifols SA, Terumo Corporation, Haemonetics Corporation, Sarstedt AG & Co KG, Cerus Corporation, Charter Medical Ltd, Kawasumi Laboratories Inc, Macopharma SA, GenesisBPS Inc, Werfen S.A, B Braun Melsungen AG, Immucor Inc, Kaneka Corporation, Nipro Medical Corporation, Teleflex Incorporated, Smiths Medical, HLL Lifecare Limited.
Access The Complete Blood Transfusion Diagnostics Market Report:
https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report
Which Region Holds The Largest Share In The Blood Transfusion Diagnostics Market?
North America was the largest region in the blood transfusion diagnostics market in 2025. Western Europe was the second-largest region in the blood transfusion diagnostics industry. The regions covered in the blood transfusion diagnostics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access a Customized Blood Transfusion Diagnostics Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/customise?id=2494&type=smp
Browse Through More Reports Similar to the Global Blood Transfusion Diagnostics Market 2026, By The Business Research Company
Blood Group Typing Market Report 2026
https://www.thebusinessresearchcompany.com/report/blood-group-typing-global-market-report
Dialysis Devices And Equipment Market Report 2026
Hemodialysis And Peritoneal Dialysis Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model